82 FR 43543 - Clinical Laboratory Improvement Advisory Committee (CLIAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 179 (September 18, 2017)

Page Range		43543-43544
FR Document		2017-19498

In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting for the Clinical Laboratory Improvement Advisory Committee (CLIAC). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. The public is also welcome to view the meeting by webcast http://cdclabtraining.adobeconnect.com/cliac.

Federal Register, Volume 82 Issue 179 (Monday, September 18, 2017)

[Federal Register Volume 82, Number 179 (Monday, September 18, 2017)]
[Notices]
[Pages 43543-43544]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-19498]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC), announces the 
following meeting for the Clinical Laboratory Improvement Advisory 
Committee (CLIAC). This meeting is open to the public, limited only by 
the space available. The meeting room accommodates approximately 100 
people. The public is also welcome to view the meeting by webcast 
http://cdclabtraining.adobeconnect.com/cliac.

DATES: The meeting will be held on November 1, 2017, 8:30 a.m. to 5:00 
p.m., EDT and November 2, 2017, 8:30 a.m. to 12:00 p.m., EDT.

ADDRESSES: CDC, 2500 Century Center Boulevard, Rooms 1200/1201, 
Atlanta, Georgia 30345 and http://cdclabtraining.adobeconnect.com/cliac.

FOR FURTHER INFORMATION CONTACT: Nancy Anderson, MMSc, MT(ASCP), Chief, 
Laboratory Practice Standards Branch, Division of Laboratory Systems, 
Center for Surveillance, Epidemiology and Laboratory Services, Office 
of Public Health Scientific Services, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia 
30329-4018, telephone (404) 498-2741; [email protected].

SUPPLEMENTARY INFORMATION: Purpose: This Committee is charged with 
providing scientific and technical advice and guidance to the Secretary 
of Health and Human Services (HHS); the Assistant Secretary for Health; 
the Director, Centers for Disease Control and Prevention; the 
Commissioner, Food and Drug Administration (FDA); and the 
Administrator, Centers for Medicare and Medicaid Services (CMS). The 
advice and guidance pertain to general issues related to improvement in 
clinical laboratory quality and laboratory medicine practice and 
specific questions related to possible revision of the Clinical 
Laboratory Improvement Amendment (CLIA) standards. Examples include 
providing guidance on studies designed to improve safety, 
effectiveness, efficiency, timeliness, equity, and patient-centeredness 
of laboratory services; revisions to the standards under which clinical 
laboratories are regulated; the impact of proposed revisions to the 
standards on medical and laboratory practice; and the modification of 
the standards and provision of non-regulatory guidelines to accommodate 
technological advances, such as new test methods, the electronic 
transmission of laboratory information, and mechanisms to improve the 
integration of public health and clinical laboratory practices.
    Matters To Be Considered: The agenda will include agency updates 
from CDC, Centers for Medicare and Medicaid Services (CMS), and The 
Food and Drug Administration (FDA). Presentations and discussions will 
focus on laboratory testing in the era of telemedicine; antibiotic 
resistance testing issues; culture independent diagnostic tests; and a 
report from the Institute of Medicine (IOM) CLIAC workgroup. Agenda 
items are subject to change as priorities dictate.
    All people attending the CLIAC meeting in-person are required to 
register for the meeting online at least 5 business days in advance for 
U.S. citizens and at least 30 business days in advance for 
international registrants. Register at: https://wwwn.cdc.gov/cliac/ cliac/. 
Register by scrolling down and clicking the ``Register for this 
Meeting'' button and completing all forms according to the instructions 
given. Please complete all the required fields before submitting your 
registration and submit no later than October 25, 2017 for U.S. 
registrants and September 19, 2017 for international registrants.
    It is the policy of CLIAC to accept written public comments and 
provide a brief period for oral public comments on agenda items. Public 
comment periods for each agenda item are scheduled immediately prior to 
the Committee discussion period for that item. In general, each 
individual or group requesting to make oral comments will be limited to 
a total time of five minutes (unless otherwise indicated). To assure 
adequate time is scheduled for public comments, speakers should notify 
the contact person below at least one week prior to the meeting date. 
For individuals or groups unable to attend the meeting, CLIAC accepts 
written comments until the date of the meeting (unless otherwise 
stated). However, it is requested that comments be submitted at least 
one week prior to the meeting date so that the comments may be made 
available to the Committee for their consideration and public 
distribution.

[[Page 43544]]

Written comments, one hard copy with original signature, should be 
provided to the contact person at the mailing or email address below, 
and will be included in the meeting's Summary Report.
    The CLIAC meeting materials will be made available to the Committee 
and the public in electronic format (PDF) on the internet instead of by 
printed copy. Check the CLIAC Web site on the day of the meeting for 
materials: https://wwwn.cdc.gov/cliac/.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-19498 Filed 9-15-17; 8:45 am]
 BILLING CODE 4163-19-P

43544 Federal Register / Vol. 82, No. 179 / Monday, September 18, 2017 / Notices

Written comments, one hard copy with four-year terms. Selection of members is (telephone numbers, mailing address,
original signature, should be provided based on candidates’ qualifications to email address)
to the contact person at the mailing or contribute to the accomplishment of D At least one letter of
email address below, and will be HICPAC objectives https:// recommendation from person(s) not
included in the meeting’s Summary www.cdc.gov/hicpac/. employed by the U.S. Department of
Report. DATES: Nominations for membership on Health and Human Services.
The CLIAC meeting materials will be the HICPAC be received no later than (Candidates may submit letter(s) from
made available to the Committee and November 30, 2017. Packages received current HHS employees if they wish,
the public in electronic format (PDF) on after this time will not be considered for but at least one letter must be submitted
the internet instead of by printed copy. the current membership cycle. by a person not employed by an HHS
Check the CLIAC Web site on the day ADDRESSES: All nominations should be agency (e.g., CDC, NIH, FDA, etc.).
of the meeting for materials: https:// mailed to HICPAC, Division of Nominations may be submitted by the
wwwn.cdc.gov/cliac/. Healthcare Quality Promotion, NCEZID, candidate him- or herself, or by the
The Director, Management Analysis CDC, 1600 Clifton Road NE., Mailstop person/organization recommending the
and Services Office, has been delegated A–07, Atlanta, Georgia 30333, emailed candidate.
the authority to sign Federal Register (recommended) to hicpac@cdc.gov, or The Director, Management Analysis
notices pertaining to announcements of faxed to (404) 639–4043. and Services Office, has been delegated
meetings and other committee FOR FURTHER INFORMATION CONTACT: Erin the authority to sign Federal Register
management activities, for both the Stone, M.S., HICPAC, Division of notices pertaining to announcements of
Centers for Disease Control and Healthcare Quality Promotion, NCEZID, meetings and other committee
Prevention and the Agency for Toxic CDC, 1600 Clifton Road NE., Mailstop management activities for both CDC and
Substances and Disease Registry. A–07, Atlanta, Georgia 30333; the Agency for Toxic Substances and
Elaine L. Baker, Telephone (404) 639–4045; hicpac@ Disease Registry.
Director, Management Analysis and Services cdc.gov. Elaine L. Baker,
Office, Centers for Disease Control and SUPPLEMENTARY INFORMATION: The U.S. Director, Management Analysis and Services
Prevention. Department of Health and Human Office, Centers for Disease Control and
[FR Doc. 2017–19498 Filed 9–15–17; 8:45 am] Services policy stipulates that Prevention.
BILLING CODE 4163–19–P committee membership be balanced in [FR Doc. 2017–19501 Filed 9–15–17; 8:45 am]
terms of points of view represented, and BILLING CODE 4163–18–P
the committee’s function. Appointments
DEPARTMENT OF HEALTH AND shall be made without discrimination
HUMAN SERVICES on the basis of age, race, ethnicity, DEPARTMENT OF HEALTH AND
gender, sexual orientation, gender HUMAN SERVICES
Centers for Disease Control and identity, HIV status, disability, and
Prevention cultural, religious, or socioeconomic Centers for Disease Control and
status. Nominees must be U.S. citizens, Prevention
Solicitation of Nominations for
and cannot be full-time employees of
Appointment to the Healthcare [30Day–17–17ABE]
the U.S. Government. Current
Infection Control Practices Advisory
participation on federal workgroups or Agency Forms Undergoing Paperwork
Committee (HICPAC)
prior experience serving on a federal Reduction Act Review
ACTION: Notice. advisory committee does not disqualify
a candidate; however, HHS policy is to The Centers for Disease Control and
SUMMARY: The Centers for Disease avoid excessive individual service on Prevention (CDC) has submitted the
Control and Prevention (CDC) is seeking advisory committees and multiple following information collection request
nominations for membership on the committee memberships. Committee to the Office of Management and Budget
HICPAC. The HICPAC consists of 14 members are Special Government (OMB) for review and approval in
experts in fields including but not Employees, requiring the filing of accordance with the Paperwork
limited to, infectious diseases, infection financial disclosure reports at the Reduction Act of 1995. The notice for
prevention, healthcare epidemiology, beginning and annually during their the proposed information collection is
nursing, clinical microbiology, surgery, terms. CDC reviews potential candidates published to obtain comments from the
hospitalist medicine, internal medicine, for HICPAC membership each year, and public and affected agencies.
epidemiology, health policy, health provides a slate of nominees for Written comments and suggestions
services research, public health, and consideration to the Secretary of HHS from the public and affected agencies
related medical fields. Nominations are for final selection. HHS notifies selected concerning the proposed collection of
being sought for individuals who have candidates of their appointment near information are encouraged. Your
expertise and qualifications necessary to the start of the term in July 2018, or as comments should address any of the
contribute to the accomplishments of soon as the HHS selection process is following: (a) Evaluate whether the
the committee’s objectives. Nominees completed. Note that the need for proposed collection of information is
will be selected based on expertise in different expertise varies from year to necessary for the proper performance of
the fields of infectious diseases, year and a candidate who is not selected the functions of the agency, including
infection prevention, healthcare whether the information will have
sradovich on DSKBBY8HB2PROD with NOTICES

in one year may be reconsidered in a
epidemiology, nursing, environmental subsequent year. practical utility; (b) Evaluate the
and clinical microbiology, surgery, Nominees must be U.S. citizens, and accuracy of the agencies estimate of the
internal medicine, epidemiology, health cannot be full-time employees of the burden of the proposed collection of
policy, health services research, and U.S. Government. Candidates should information, including the validity of
public health. Federal employees will submit the following items: the methodology and assumptions used;
not be considered for membership. D Current curriculum vitae, including (c) Enhance the quality, utility, and
Members may be invited to serve for complete contact information clarity of the information to be

VerDate Sep<11>2014 16:54 Sep 15, 2017 Jkt 241001 PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 E:\FR\FM\18SEN1.SGM 18SEN1

Document Created: 2017-09-16 00:51:31
Document Modified: 2017-09-16 00:51:31

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of meeting.
Dates		The meeting will be held on November 1, 2017, 8:30 a.m. to 5:00 p.m., EDT and November 2, 2017, 8:30 a.m. to 12:00 p.m., EDT.
Contact		Nancy Anderson, MMSc, MT(ASCP), Chief, Laboratory Practice Standards Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road NE., Mailstop F-11, Atlanta, Georgia 30329-4018, telephone (404) 498-2741; [email protected]
FR Citation		82 FR 43543

82 FR 43543 - Clinical Laboratory Improvement Advisory Committee (CLIAC)

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 82, Issue 179 (September 18, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention